pancreatic cancer Bluestar Genomics Raises $70M in Series C Funding Round The San Diego-based early cancer detection firm has also appointed Felix Fang and Craig Venter to its scientific advisory board. BostonGene, Medical College of Wisconsin Partner on Pancreatic Cancer Biomarker Research The partners will look for patterns in patients' exome sequencing and transcriptomics data to try to predict treatment response. Immunovia Preparing to Launch Laboratory-Developed Test for Pancreatic Cancer Premium The firm said that recent validation studies have shown that a positive result with its PanCan-d microarray test could accelerate diagnosis for high-risk individuals. Guardant AACR Data Highlights Value of Clinical Test Database to Drive Drug Resistance Discoveries Researchers used the company's large clinical-genomic database to characterize HRD reversion mutations and explore their potential function in patient resistance to PARP inhibitors. TGen-Led Team Spots Pediatric, Pancreatic Cancer From cfDNA Fragments in Urine Premium The liquid biopsy method analyzes fragment ends within recurrently protected regions in cell-free DNA from a patient's urine sample. Feb 1, 2021 Interpace, Rutgers, Mass General Sign Deal for Pancreatic Cyst Risk Assessment Biomarker Dec 17, 2020 Merus, Sema4 Partner to Accelerate Enrollment in Zenocutuzumab Trial Nov 2, 2020 Bluestar Genomics Eyes Pan-Cancer Early Detection With Epigenetic Assay Technology Premium Oct 16, 2020 Pancreatic Cancer Subtype With Poor Outcomes Shows Low Methylation, High Interferon Signature Oct 13, 2020 Pancreatic Cancer Action Network Launches Adaptive Clinical Trial Platform Oct 12, 2020 Wales to Routinely Screen Cancer Patients With Yourgene Elucigene Test Sep 24, 2020 Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test Sep 16, 2020 Startup Stitch Bio Bets on CRISPR Tech to Render Cancer Cells With Gene Fusions Druggable Premium Sep 15, 2020 Pancreatic Cancer Treatment Clues Uncovered From Genomic, Chromatin Profiles Sep 9, 2020 NYGC Initiative Receives up to $2.1M for Cancer Studies in Ethnic Minorities Jul 31, 2020 Exact Sciences Positions Itself as Cancer Testing Provider of Future as COVID Crisis Continues Premium Jul 29, 2020 Pancreatic Cancer Action Network, GeneCentric Therapeutics Launch Research Partnership Jun 11, 2020 Seven Bridges Building Research Platform for PanCAN May 29, 2020 Tumor Microbiome Appears to Vary With Cancer Type Apr 22, 2020 Pancreatic Cancer Clinical Risk Prediction Appears to Improve With Genetic, Biomarker Data Apr 16, 2020 Multi-Analyte Liquid Biopsy Panel May Aid in Pancreatic Cancer Detection, Staging Premium Apr 16, 2020 Human Tumor Atlas Network Team Shares Strategy for Tracking Tumor Transitions Mar 30, 2020 Myriad Genetics Seeks Japan Approval for Advanced Pancreatic, Prostate Cancer Companion Diagnostic Mar 12, 2020 Perthera's Virtual Molecular Tumor Board Can Improve Patient Outcomes, Overcome Access Barriers Premium Feb 11, 2020 Biological Dynamics Aims to Boost Adoption of Raw Sample Biomarker Tech Through Microsoft Program Premium Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.